Calculation of the percentage of CD133+ cells in invading cells revealed that approximately 30% invasive glioma cells expressed CD133 (53/175), while less than 1% non-invasive glioma cells were CD133 positive (6/713) (Figure 2C). This evidence concerns the gene PROM1 and central nervous system cancer.